Recombinant Human IL-9 Protein, CF Summary
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 200 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Recombinant Human IL-9 (Catalog # 11081-IL) induces MO7e human megakaryocytic leukemic cell proliferation. The ED50 for this effect is 0.200‑1.00 ng/mL
2 μg/lane of Recombinant Human IL‑9 Protein (Catalog # 11081-IL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 26-38 kDa.
Interleukin-9 (IL-9), also known as P40 and MEA (mast cell growth-enhancing activity), is a 30-40 kDa glycosylated member of a cytokine family that includes Interleukins-2, -4, -7, -15, and -21. These proteins utilize heteromeric receptors containing the Common gamma chain ( gamma c) in addition to ligand-specific subunits. IL-9 interacts selectively with IL-9 R which then associates with gamma c to form the functional receptor complex. IL-9 contributes to allergic inflammation, autoimmunity-induced inflammation, parasite clearance from the GI tract, and Treg-mediated immune suppression (1, 2). It enhances the expansion and recruitment of mast cells and eosinophils as well as the production of IgE and Th2 cytokines (3‑6). It is required for anaphylactic responses to ingested allergens but not to systemic allergens (7). IL-9 plays multiple roles in the development and function of subsets within the CD4+ T cell lineage (8). It is expressed by activated Th9, Th17, Treg, and Th2 cells (3, 9‑12). IL-9 acts as an autocrine growth and activation factor for Th17, Treg, and mast cells (3, 11, 13). It also can inhibit immune responses by enhancing the suppressive properties of Treg and by recruiting immune-suppressive mast cells to sites of inflammation (11, 12). Mature human IL-9 shares 57% amino acid sequence identity with mouse and rat IL-9 (14, 15).
- Noelle, R.J. and E.C. Nowak (2010) Nat. Rev. Immunol. 10:683.
- Goswami, R. and M.H. Kaplan (2011) J. Immunol. 186:3283.
- Nowak, E.C. et al. (2009) J. Exp. Med. 206:1653.
- Townsend, M.J. et al. (2000) Immunity 13:573.
- Leech, M.D. and R.K. Grencis (2006) J. Immunol. 176:2505.
- Fawaz, L.M. et al. (2007) J. Allergy Clin. Immunol. 120:1208.
- Osterfeld, H. et al. (2010) J. Allergy Clin. Immunol. 125:469.
- Jabeen, R. and M.H. Kaplan (2012) Curr. Opin. Immunol. 24:303.
- Tan, C. et al. (2010) J. Immunol. 185:6795.
- Jager, A. et al. (2009) J. Immunol. 183:7169.
- Elyaman, W. et al. (2009) Proc. Natl. Acad. Sci. USA 106:12885.
- Lu, L.-F. et al. (2006) Nature 442:997.
- Stassen, M. et al. (2000) J. Immunol. 164:5549.
- Yang, Y.-C. et al. (1989) Blood 74:1880.
- Renauld, J.-C. et al. (1990) Cytokine 2:9.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human IL-9 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human IL-9 Protein, CF and earn rewards!
Have you used Recombinant Human IL-9 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image